RAB-Symposium - Regulatory Autoantibodies Targeting GPCRs
Lübeck, Germany | September 15-16, 2022
Dear Sir or Madam, dear Colleagues,
It gives me great pleasure to announce the fourth symposium on regulatory autoantibodies targeting G protein-coupled receptors (GPCRs) in Lübeck.
GPCRs are involved in a variety of physiological and pathophysiological processes. So far, numerous therapeutics have been developed against GPCRs, with a focus on the development of small molecules and monoclonal antibodies for the treatment of cancer, infections, metabolic disorders or inflammatory diseases. Recently, functional autoantibodies targeting GPCRs have been related to several diseases specific manifestations, highlighting a potential new area for therapeutic intervention. The aim of this symposium is therefore to bring together current knowledge on the role of GPCRs in different diseases, their mode of action in immunoregulation and pathogenesis.
I hereby cordially invite you to participate in this stimulating symposium with outstanding speakers from the field of GPCR research and fruitful discussions as well as poster sessions. I look forward to welcoming you to the beautiful Hanseatic city of Lübeck and encourage you and your colleagues to contribute to this exciting meeting.
Welcome to this Symposium.